Companies seek second GLP-1 revolution-in pill form.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40245133.
- Also identified by DOI 10.1126/science.ady2624.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Smaller, easier to make drug compounds could treat obesity and diabetes with fewer side effects.
Medical subject headings
- Anti-Obesity Agents
- Diabetes Mellitus, Type 2
- Glucagon-Like Peptide 1
- Hypoglycemic Agents
- Obesity